RE:We got the:Weed’s leadership credentials are stellar and should include vision, multiple product/medicinal verticals with contracts expected to garner “30-40% of the initial Canadian market”. But when the “smoke clears”, it comes down to “show me the money”. I would like Bruce in the conference call to even more clearly define the expected financial success post October. And there is no one better to articulate the real value of this investment more than Bruce-articulate, honest and thorough. GLTA true Canopy investors.